Roxadustat for treatment of anemia in a cancer patient with end-stage renal disease: A case report

BACKGROUND: Most cancer patients are accompanied by anemia, which will be more serious when combined with end-stage renal disease (ESRD). At present, cancer-related anemia and renal anemia treatments mainly include erythropoiesis-stimulating agents (ESAs), iron supplementation, and blood transfusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qiao-Qiao, Li, Jing, Liu, Bin, Wang, Chun-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294907/
https://www.ncbi.nlm.nih.gov/pubmed/35979316
http://dx.doi.org/10.12998/wjcc.v10.i19.6587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294907/
https://www.ncbi.nlm.nih.gov/pubmed/35979316
http://dx.doi.org/10.12998/wjcc.v10.i19.6587

Ejemplares similares